Why perpetual COVID-19 vaccine boosting 'isn't an ideal option'


The prospect of COVID-19 booster shots have been looming since even before any vaccines were granted approval late last year. Most scientists believe boosters will be necessary at some point, though it's not clear when, but they also may want to make sure those bonus shots aren't needed all that often in the long run, Katherine Wu reported for The Atlantic on Wednesday.
"Boosting in perpetuity isn't an ideal option, if we can avoid it," Wu wrote. That's partly because side effects may become more intense with each passing shot, but it also may simply exhaust the human immune system. If people are vaccinated too frequently, then cells will eventually "stop learning efficiently from the material vaccines provide, and essentially 'burn out' from information overload," Wu reported, citing John Wherry, an immunologist at the University of Pennsylvania.
Ultimately, Wu wrote, "the world is better served when we're judicious with vaccines ... and inoculate as needed, no more, no less." Read more at The Atlantic.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
What's at stake in the Mahmoud Khalil deportation fight?
Talking Points Vague accusations and First Amendment concerns
By Joel Mathis, The Week US Published
-
Why is a new Air Force One taking so long to build?
The Explainer Trump may look for alternatives for his new plane
By Joel Mathis, The Week US Published
-
New and notable podcasts for March
Feature The MeidasTouch Podcast and The Magnificent Others With Billy Corgan
By The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published